Hydroxychloroquine is ineffective in the face of the Covid-19 according to a study published Thursday in Brazil, where the president Jair Bolsonaro, contaminated by the disease, but she is publicly promoting.
Conducted in 55 hospitals of the country, the clinical trial published by the New England Journal of Medicine aimed to establish if this drug is controversial, combined or not to the antibiotic azithromycin, can improve the condition of patients with mild or moderate Covid-19.
In the Face of the pandemic, the government Bolsonaro recommends that since last may the employment of hydroxychloroquine, or the anti-malarial chloroquine, associated with azithromycin.
The leader of the extreme right, which has announced to have tested positive to the Covid-19 on 7 July, has repeatedly claimed to have seen his state of health be improved by hydroxychloroquine. Sunday, he even held up a box of this drug is controversial – the us president Donald Trump has also touted the merits.
But according to several randomized controlled trials, the drug is ineffective in the face of the virus, and may have adverse side effects. The brazilian study, conducted by a group of researchers and physicians under the name of Coalition Covid-19 Brazil, came to the same conclusion.
Driving on 667 patients, it has been established that those treated with hydroxychloroquine were exposed to more problems in the heart and liver.
The date of Thursday, Brazil, which is after the United States is the country most heavily hit by the Covid-19, there were nearly 2.3 million cases of infection and more of 84,000 deaths.
Mr. Bolsonaro, a former member of the far-right has often downplayed the seriousness of the pandemic, it has long qualified as a “grippette”. He walked Thursday on a motorcycle and is maintained without the mask with sweepers near his home in Brasilia, according to photos released in the media.